Eva Domingo-Domenech, MD on How ADCETRIS May Impact Existing Treatment in sALCL?

Eva Domingo-Domenech, MD on How ADCETRIS May Impact Existing Treatment in sALCL?

Cancer-News

1 month
9 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Eva Domingo-Domenech, MD of Institut Català d'Oncologia – Hospitalet discusses ADCETRIS for Treatment of Adult Patients with Previously Untreated sALCL: How ADCETRIS may impact the existing sALCL treatment landscape?
Up Next Autoplay